Abstract

Abstract: The current molecular advances in lung fibrosis pathogenesis distend beyond the cellular to involve subcellular and molecular levels. Lung fibrogenesis and autophagy impairment are tight-ly associated. Autophagy is involved in cell cycle control and regulation of the intracellular micro-environment. Degradation of impaired intracellular organelles and biproducts is crucial to maintain-ing a healthy cell and preventing its metaplasia / transdifferentiation to a pathological cell. Autoph-agy modifies the metabolism of alveolar epithelial cells, endothelial cells, and lung fibroblasts. Au-tophagy upregulation induces local lung fibroblast hyperactivity and fibrosis. Several molecular triggers were found to induce lung fibroblast autophagy including TGFβ by inhibition of the PI3K/AKT/mTOR. However, physiologically, a balance is retained between autophagy inducers and inhibitors. Each type of autophagy plays its role in the initiation and progression of lung fibro-sis. The pathogenesis of pulmonary fibrosis is multifactorial and involves dysfunction / dysregula-tion of alveolar epithelial cells, fibroblasts, monocyte-derived macrophages, and endothelial cells. The deposition of extracellular matrix proteins, the remodeling of the lung architecture and the mo-lecular changes include impaired glycolysis, mitochondrial oxidation, gene expression modification, altered phospholipid and sphingolipid metabolism, and dysregulated protein folding lead to repro-gramming of lung fibroblast into myofibroblast and their activation. The paper thoroughly addresses the molecular triggers and inhibitors of lung fibroblast autophagy in lung fibrosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call